Click on images to enlarge

4 photo(s) Updated on: 07/29/2021
  • Hypercellular smear preparation composed of pleomorphic primitive-to-rhabdoid appearing cells.
  • Tumor cells show various morphologies, including rhabdoid, "small round blue cell," and a pale vacuolated appearance.
  • Tumor cells show various morphologies, including rhabdoid, "small round blue cell," and a pale vacuolated appearance.
  • INI-1 immunostain shows loss of nuclear expression in tumor cells. Notice endothelial cells that can serve as an internal control.

Atypical Teratoid/Rhabdoid Tumor

Answer: C - Atypical teratoid/rhabdoid tumor, WHO Grade 4

Atypical teratoid/rhabdoid tumor (AT/RT) is an aggressive primary CNS malignancy. Similar to  to renal and extrarenal rhabdoid tumors, these are tumors of the very young, with most cases being diagnosed within the first 3 years of life. 

Nearly all AT/RTs are intracranial, occurring in the supratentorial and posterior fossa compartments in approximately equal frequencies. Within these regions, they are most commonly found intracerebrally and cerebellum/cerebellopontine angle, respectively.  Rarely, they can appear to arise from the ventricular system, as in this case. 

While AT/RTs are associated with a classic rhabdoid morphology, these are generally undifferentiated (high-grade) tumors that can simulate several cell lineages both histologically and immunohistochemically. This can include variable amounts of epithelial (EMA, CK), glial (GFAP/S100), primitive neuronal (synaptophysin), and mesenchymal (SMA/desmin) areas. Although such features are highly suggestive of AT/RT,  definitive diagnosis requires loss of INI-1 nuclear expression (see image) or biallelic inactivation of the corresponding SMARCB1 gene. Rare cases can be caused by SMARCA4 inactivation, corresponding to BRG1 protein loss.  


Powered by Wild Apricot Membership Software